MAC UK   Report issue

For profit Phase 2

Organization Overview

First Clinical Trial
2020
NCT04686916
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

MAC UK